Reversible cardiomyopathy in a patient with Marfan's syndrome. Case report

Adriana E Viñas-Mendieta1, Jesús K Cárdenas-Gallegos2, Roberto Baltodano-Arellano1

  • 1Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru. Hospital Nacional Guillermo Almenara Irigoyen Lima Peru.

Insights

Marfan syndrome patients can experience heart failure due to arrhythmias and aortic dilation. Successful treatment improved heart function and reduced key cardiac markers.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Connective Tissue Disorders

Background:

  • Marfan syndrome is a genetic disorder affecting connective tissue, leading to cardiovascular complications like aortic root dilation and non-ischemic cardiomyopathy.
  • Arrhythmias are a known complication, but their impact on heart function in Marfan syndrome is not well-documented.

Observation:

  • A 21-year-old male with Marfan syndrome presented with heart failure, frequent supraventricular arrhythmias, and significant aortic root dilation.
  • The patient underwent ablation for arrhythmias and aortic root repair surgery (Tirone David Procedure).

Findings:

  • Post-treatment, the patient showed significant clinical improvement.
  • Left ventricular ejection fraction increased from 33% to 46%.
  • Left ventricular end-diastolic volume decreased from 90 ml/m² to 77 ml/m², and NT-proBNP levels dropped from 1100 pg/mL to 180 pg/mL.

Implications:

  • This case highlights the potential benefits of combined arrhythmia ablation and surgical repair in managing heart failure in Marfan syndrome.
  • Aggressive management of cardiovascular manifestations can lead to substantial improvements in cardiac function and patient outcomes.
  • Further research is warranted to understand the prevalence and management strategies for arrhythmias in Marfan syndrome.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...